Seegene Inks MOU With Hamilton to Develop MDx System

Dec

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Seegene Inks MOU With Hamilton to Develop MDx System

To read the full story....

Breaking News

Quest Diagnostics Prices $800M Offering of Senior Notes

NeuMoDx Molecular, Sentinel Diagnostics Partner for MDx Development

StageZero, Oncore Pharma Expand Test Deal

Former Diagnostics Executive Ordered to Pay $443K for Defrauding Investors

Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

Biocept Prices $10M Public Offering of Stocks, Warrants

Featured White Papers

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

Hologic Vaginitis Tests Offer Improvements Over Gold Standard Methods

NeuMoDx Molecular, Sentinel Diagnostics Partner for MDx Development

Biocept Prices $10M Public Offering of Stocks, Warrants

BioMérieux, Beckman Coulter, Siemens Healthineers, Others Get 510(k) Clearances in November

Sponsorships